Director · ABBOTT LABORATORIES · Common shares without par value
Side
A
Value
—
Shares
2,286
Price
—
Executed
Apr 24, 2026
Disclosed
Apr 28, 2026
Disclosure timeline4 days from execution to publication · legal deadline 2 business days
Apr 24 executedApr 28, 2026 disclosed
ABT · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+9 / 25
No reported dollar value · 43.0% of prior position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Babineaux-Fontenot Claire filed this Form 4 reporting a grant or award of ABT on Apr 24, 2026. It became public on Apr 28, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director
Babineaux-Fontenot Clairecik:0001736637
Issuer
ABBOTT LABORATORIEScik:0000001800
Revision history · 0
No field has changed since this record was first ingested.
